To further confirm whether lncRNA MIAT deficiency overcomes resistance, we tested synergy with cisplatin in NPC resistant cells and results showed that lncRNA MIAT deficiency re-sensitized cells to cisplatin (Figures 6J, K). This evidence concerns the gene MIAT and nasopharyngeal carcinoma.